The chicken chorioallantoic membrane model for isolation of CRISPR/cas9-based HSV-1 mutant expressing tumor suppressor p53.
Oncolytic viruses (OVs) have emerged as a novel cancer treatment modality, which selectively target and kill cancer cells while sparing normal ones. Among them, engineered Herpes simplex virus type 1 (HSV-1) has been proposed as a potential treatment for cancer and was moved to phase III clinical tr...
Main Authors: | Mishar Kelishadi, Hosein Shahsavarani, Alijan Tabarraei, Mohammad Ali Shokrgozar, Ladan Teimoori-Toolabi, Kayhan Azadmanesh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0286231&type=printable |
Similar Items
-
Investigation of the Possible Association between Human Cytomegalovirus and Pterygium Development
by: Mishar Kelishadi, et al.
Published: (2019-07-01) -
Prevalence of Active Cytomegalovirus Infection in Hemodialysis Patients
by: Mishar Kelishadi, et al.
Published: (2017-07-01) -
Studying the Activity of Fibroblast Growth Factor 18 and Urokinase Plasminogen Activator Receptor Promoters in Two Colon Cancer Cell Lines
by: Ladan Teimoori-Toolabi, et al.
Published: (2009-01-01) -
Presence of GB Virus C in Whole-Blood Derivatives: A Pilot Study
by: Mishar Kelishadi, et al.
Published: (2019-09-01) -
Frequency of Human Herpesvirus 6 (HHV-6) in Pterygium Using Real-Time PCR Based on SYBR-Green I Fluorescence
by: Mishar Kelishadi, et al.
Published: (2019-03-01)